Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
EuroPCR 25: Meta-Analysis from PROTECTED TAVR and BHF PROTECT-TAVI
Author(s): Rajesh Kharbanda Added: 1 month ago
EuroPCR 25 - A meta-analysis of the individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies show TAVI with cerebral embolic protection (CEP) may reduce the rate of disabling stroke compared to TAVI without CEP.We are joined by Prof Rajesh Kharbanda (Oxford Radcliffe Hospitals NHS Trust, Oxford, UK) to discuss outcomes from a meta-analysis investigating TAVI with or without… View more

Intervention
Management of CAD in TAVI
Author(s): Cian Murray , Caoimhe Ryan , Michael Cronin , et al Added: 1 month ago

Intervention
ESC 24: The EARTH-STEMI Meta-Analysis
Author(s): Gianluca Campo Added: 10 months ago
ESC Congress 2024 — Complete revascularisation is safe, reduces ischemic events for up to 4 years, and does not affect long-term mortality.We are joined onsite by Dr Gianluca Campo (University of Ferrara, Ferrara, IT) to discuss the findings from EARTH-STEMI. Previous RCTs have supported the benefit of complete revascularisation in the overall population, however, this has not been confirmed in… View more

Intervention
The ACURATE IDE Post-Hoc Analysis
Author(s): Raj Makkar Added: 1 month ago
EuroPCR 25 - Post-hoc anlysis outcomes from under-expansion of the ACURATE neo2 valve in severe aortic stenosis (AS) patients show under-expansion was associated with higher rates of death, stroke or rehospitalisation.We are joined by Dr Raj Makkar (Cedars-Sinai Heart Institute, Los Angeles, US) to discuss findings from the post-hoc analysis of the ACURATE IDE study (NCT03735667; Boston… View more

Intervention

Vascular Disease and Surgery
ACC 25: Cardiac Biomarker Analysis from the EARLY TAVR Trial
Author(s): Brian Lindman Added: 3 months ago
ACC 2025 - Primary findings from EARLY-TAVR show the benefit of early TAVR intervention was consistent across biomarker subgroups.Dr Brian Lindman (Vanderbilt University Medical Center, Nashville, US) joins us onsite at ACC 2025 to discuss findings from the primary biomarker analysis from the EARLY TAVR trial (NCT03042104; Edwards Lifesciences). The analysis investigated cardiac biomarkers in… View more

Vascular Disease and Surgery
OCT Analysis Links Cardiovascular Risk Factor Burden to Plaque Vulnerability in ACS
Added: 3 days ago Source:  Radcliffe Cardiology
A greater number of traditional cardiovascular risk factors is strongly associated with increased coronary plaque vulnerability in patients with acute coronary syndrome (ACS), particularly in culprit lesions, according to a new analysis published in JACC.¹ The study provides a direct morphological link between the cumulative burden of risk factors and the high-risk plaque features that… View more

Imaging & Diagnostics

Intervention
AI-based OCT Analysis from the BIOMAG-I FIH trial
Author(s): Hector M Garcia-Garcia Added: 1 year ago
In this interview, Prof Garcia-Garcia explains the methodology and findings of the AI-based OCT analysis and how this could impact practice in the future. View more

Intervention
Complex PCI Outcomes in a Pooled Patient Analysis From BIOFLOW- II, IV and V
Author(s): Rayyan Hemetsberger Added: 1 year ago
Dr Rayyan Hemetsberger(Medical University of Vienna, AT) led several patient-level analyses of pooled data from the BIOFLOW-II,-IV and -V trials, comparing the Orsiro DES to the Xience DES. In this interview, he presents the results of his analysis for complex vs. non-complex PCI patients. Further insights on other patient level analysis (calcified lesions, atherothrombotic risk patients) and his… View more

Intervention

Prevention & Chronic Conditions
TCT 24: Pooled Analysis of RHEIA and PARTNER 3
Author(s): Didier Tchétché Added: 8 months ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) compared to surgical aortic valve replacement (SAVR) in female patients with severe aortic stenosis.Dr Didier Tchétché (Clinique Pasteur, FR) joins us onsite at TCT Conference to discuss the pooled findings from the RHEIA (NCT04160130) and PARTNER 3 (NCT02675114) trials.RHEIA and PARTNER 3 are… View more

Demographic

Intervention
Job title: MB